読み込み中
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
前日終値
$1.495
+$0.065 · +4.55%
時間外
$1.5158
+$0.0208 · +1.39%
10月9日 19:52 ET
日中の時刻はETです。市場データは遅延する場合があります。
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
日中レンジ
現在 $1.495
52週レンジ
現在 $1.495
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
52
適正価値
センチメント
58
まちまち
リスク
70
高リスク
モメンタム
31
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
日中レンジ
現在 $1.495
52週レンジ
現在 $1.495
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（CAD） | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 1531.94万 CAD | 2452万 CAD | 2451.8万 CAD | 2066.5万 CAD | 1936.4万 CAD |
| 売上原価 | 631.17万 CAD | 1097.2万 CAD | 1246.5万 CAD | 910.2万 CAD | 838.1万 CAD |
| 粗利益 | 900.77万 CAD | 1354.8万 CAD | 1205.3万 CAD | 1156.3万 CAD | 1098.3万 CAD |
| 研究開発 | 485.73万 CAD | 494.3万 CAD | 404.3万 CAD | 1410.1万 CAD | 766.3万 CAD |
| 販売・一般管理 | 1885.83万 CAD | 1903.3万 CAD | 1913.5万 CAD | 1899.1万 CAD | 1805.5万 CAD |
| 営業費用 | 2371.56万 CAD | 2574.4万 CAD | 2581.5万 CAD | 3717.4万 CAD | 2765.6万 CAD |
| 受取利息 | — | — | 2.3万 CAD | 12.2万 CAD | 27.9万 CAD |
| 支払利息 | — | 9914 CAD | 1.9万 CAD | 3万 CAD | 8.5万 CAD |
| 減価償却費と償却費 | 157.94万 CAD | 511.9万 CAD | 573.5万 CAD | 668.5万 CAD | 376.9万 CAD |
| 営業利益 | −1470.79万 CAD | −1219.6万 CAD | −1376.2万 CAD | −2561.1万 CAD | −1667.3万 CAD |
| 純利益 | −1373.51万 CAD | −3023.4万 CAD | −2611.5万 CAD | −2656万 CAD | −1670.9万 CAD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
